Vimian Group aktie (VIMIAN) | Pressmeddelande - Börskollen
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

•Läs mer: Investera i räntebärande lån – Historisk årlig avkastning på 9,9 % (annons)

Pressmeddelanden från Vimian Group

 Bevaka pressreleaser
Kurs från TradingView
StartNyheterPressreleaserRiktkurserInsynshandelBlankningAnalyserBloggarVideosPodcasts

Vimians delårsrapport för det tredje kvartalet 2024

Fortsatt tvåsiffrig tillväxt och marginalexpansion

MFN • 24 Oct 07:45

Inbjudan till Vimians delårsrapport för tredje kvartalet 2024

Vimian Group AB publicerar sin delårsrapport för det tredje kvartalet 2024 torsdagen den 24 oktober 2024 kl.

MFN • 18 Oct 10:00

Valberedning inför Vimians årsstämma 2025

Valberedningen för Vimian Group har utsetts.

MFN • 11 Oct 10:00

Vimian Group går in i ny MedTech nisch genom förvärvet av globalt företag inom veterinärmedicinsk tandvård

Vimian Group AB (publ) har idag tecknat avtal om att förvärva 100 procent av iM3 Dental Limited på Irland och 80 procent av iM3 Pty Ltd i Au...

MFN • 06 Sep 08:04

Vimians delårsrapport för det andra kvartalet 2024

Stark organisk tillväxt och marginalexpansion

MFN • 15 Aug 07:45

Inbjudan till Vimians delårsrapport för det andra kvartalet 2024

Vimian Group AB publicerar sin delårsrapport för det andra kvartalet 2024 torsdagen den 15 augusti 2024 kl.

MFN • 06 Aug 10:00

Fidelio utfärdar köpoptioner till Vimians styrelseordförande Magnus Welander

Vimian Group AB (publ) har informerats om att bolagets största aktieägare Fidelio Vet Holding AB ("Fidelio") har åtagit sig att utfärda 100 ...

MFN • 27 Jun 15:30

Omvandling av C-aktier i Vimian Group AB

Antalet aktier och röster i Vimian Group AB (publ) ("Vimian") har ändrats till följd av omvandling av 7 446 367 C-aktier till stamaktier som...

MFN • 19 Jun 16:30

Vimian ingår förlikningsavtal med en av huvudsäljarna av VOI i den tidigare kommunicerade skadeståndsprocessen som är relaterad till den amerikanska patenttvisten

Vimian Group ABs (publ) dotterbolag, del av Vimians MedTech segment, har ingått förlikningsavtal med en av huvudsäljarna av Veterinary Ortho...

MFN • 11 Jun 08:00

Kommuniké från årsstämman i Vimian Group AB (publ) den 22 maj 2024

Vimian har idag den 22 maj 2024 hållit årsstämma. Årsstämman genomfördes med fysisk närvaro av aktieägare och med möjlighet för aktieägare a...

MFN • 22 May 12:20

Vimians delårsrapport för det första kvartalet 2024

Normalisering av försäljningsmönstret i MedTech

MFN • 02 May 07:45

Inbjudan till Vimians delårsrapport för första kvartalet 2024

Vimian Group AB kommer att publicera sin delårsrapport för första kvartalet 2024 torsdagen den 2 maj 2024, klockan 07.

MFN • 22 Apr 10:00

Kallelse till årsstämma i Vimian Group AB (publ)

Vimian Group AB (publ) (”Vimian”), org.nr 559234-8923, med säte i Stockholm, kallar till årsstämma den 22 maj 2024 kl.

MFN • 19 Apr 08:30

Vimian publicerar Års- och Hållbarhetsredovisning för 2023

Vimian Group publicerar Årsredovisning för 2023 på svenska och engelska.

MFN • 10 Apr 08:00

Vimian announces final outcome in the oversubscribed rights issue

The final outcome of the rights issue in Vimian Group AB (publ) ("Vimian") of up to approximately SEK 1,633 million (the “Rights Issue”) sho...

MFN • 05 Apr 08:00

Vimian offentliggör prospekt avseende företrädesemissionen

Vimian offentliggör prospekt avseende företrädesemissionen

MFN • 18 Mar 12:45

Vimian resolves on a rights issue of up to approximately SEK 1,633 million to finance future M&A, announces new financial targets and declares its intention to change listing venue

The Board of Directors of Vimian Group AB (publ) (“Vimian” or the “Company”) has, based on the authorisation from the Annual General Meeting...

MFN • 08 Mar 07:34

Vimian announces new financial targets

The Board of Directors of Vimian AB (publ) has today adopted new financial targets.

MFN • 08 Mar 07:30

Magnus Welander proposed as new Chairman of the Board in Vimian Group

The Nomination Committee in Vimian Group proposes that Magnus Welander is appointed new Chairman of the Board of Directors at the Annual Gen...

MFN • 28 Feb 08:00

Vimian reaches settlement agreement with one of the sellers in the indemnification process relating to the US patent dispute

Vimian Group AB (publ)’s subsidiaries, part of Vimian’s MedTech segment, have reached a settlement agreement with Dr.

MFN • 26 Feb 21:50

Vimian’s year-end report for 2023

A strong platform for profitable growth

MFN • 15 Feb 07:45

Invitation to Vimian’s year-end report for 2023

Vimian Group AB will publish its year-end report for 2023 on Thursday, 15 February 2024, at 07.

MFN • 05 Feb 11:00

Vimian appoints Patrik Eriksson as new CEO

Vimian Group AB (publ) (“Vimian”) appoints Patrik Eriksson Chief Executive Officer, effective 1 January 2024.

MFN • 21 Dec 2023 15:45

Colleen Flesher, Co-CEO of Vimian’s MedTech segment Movora, steps down

Colleen Flesher has decided to step down from the Vimian Group management team and the position as Co-CEO Movora, to pursue an opportunity o...

MFN • 15 Nov 2023 08:15

Vimian’s Interim Report for the third quarter of 2023

Strong organic growth and operational cash flow

MFN • 08 Nov 2023 07:45

Nomination Committee for Vimian’s 2024 Annual General Meeting

The Nomination Committee for Vimian Group has been appointed.

MFN • 06 Nov 2023 10:00

Invitation to Vimian’s Interim Report for the third quarter of 2023

Vimian Group AB will publish its Interim Report for the third quarter of 2023 on Wednesday, 8 November 2023, at 07.

MFN • 31 Oct 2023 13:30

Conversion of C-shares in Vimian Group AB

The number of votes in Vimian Group AB (publ) (“Vimian”) has changed as a result of (i) redemption of 5,320 C-shares, and (ii) conversion of...

MFN • 14 Sep 2023 14:00

Vimian’s Interim Report for the second quarter of 2023

Strong growth in resilient market

MFN • 17 Aug 2023 07:45

Invitation to Vimian’s Interim Report for the second quarter of 2023

Vimian Group AB will publish its Interim Report for the second quarter of 2023 on Thursday, 17 August 2023, at 07.

MFN • 07 Aug 2023 11:00

Vimian Group AB (publ) CEO to step down at the end of the year

Today, Vimian Group AB (publ) (“Vimian”) announces that CEO Fredrik Ullman, following consultation with the Board, steps down as CEO.

MFN • 29 Jun 2023 14:15

Kommuniké från årsstämman i Vimian Group AB (publ) den 2 juni 2023

Vimian har idag den 2 juni 2023 hållit årsstämma. Årsstämman genomfördes med fysisk närvaro av aktieägare och med möjlighet för aktieägare a...

MFN • 02 Jun 2023 09:45

Update in indemnification process relating to US patent dispute

Following the settlement in the US patent dispute on 4 April, Vimian has initiated the process to retrieve compensation from the Sellers of ...

MFN • 07 May 2023 08:30

Vimian’s Interim Report for the first quarter of 2023

Positive start to the year

MFN • 04 May 2023 07:45

Kallelse till årsstämma i Vimian Group AB (publ)

Vimian Group AB (publ) (”Vimian”), org.nr 559234-8923, med säte i Stockholm, kallar till årsstämma den 2 juni 2023 kl.

MFN • 03 May 2023 08:00

Vimian Group publishes Annual Report for 2022

Vimian Group has published its Annual Report for 2022.

MFN • 03 May 2023 07:30

Invitation to Vimian’s Interim Report for the first quarter of 2023

Vimian Group AB will publish its Interim Report for the first quarter of 2023 on Thursday, 4 May 2023, at 07.

MFN • 20 Apr 2023 10:00

Vimian resolves on an issue of shares to the sellers of Kahu Vet Group

Vimian Group today announces that the board of directors, based on the authorization from the 2022 annual general meeting, has resolved on a...

MFN • 14 Apr 2023 12:15

Vimian subsidiary reaches settlement agreement resolving patent litigation with DePuy Synthes

Vimian Group AB (publ)’s (“Vimian”) subsidiary, Veterinary Orthopedic Implants, LLC (“VOI”), part of Vimian’s MedTech segment and Fidelio, h...

MFN • 04 Apr 2023 06:45

Kommuniké från extra bolagsstämma i Vimian Group AB (publ) den 24 mars 2023

Vimian har idag den 24 mars 2023 hållit extra bolagsstämma.

MFN • 24 Mar 2023 15:30

Vimian Group acquires veterinary services platform in Australia

Vimian Group has signed an agreement to acquired Vettr, a member services platform for veterinary clinics based in Brisbane, Australia.

MFN • 22 Mar 2023 09:00

Vimian’s year-end report for 2022

Solid year in challenging macroeconomy

MFN • 08 Mar 2023 07:45

Kallelse till extra bolagsstämma i Vimian Group AB (publ)

Vimian Group AB (publ) (”Vimian”), org.nr 559234-8923, med säte i Stockholm, kallar till extra bolagsstämma den 24 mars 2023 kl.

MFN • 08 Mar 2023 07:34

Vimian amends consideration parameters for the acquisition of Viking Blues Pty Ltd (the non-regulated part of Bova in Australia) and announces its intention to issue shares to finance the acquisition

Vimian has amended the share purchase agreement for the acquisition of Viking Blues Pty Ltd (the non-regulated part of Bova Australia) that ...

MFN • 08 Mar 2023 07:30

Invitation to Vimian’s year-end report for 2022

Vimian Group AB will publish its year-end report for 2022 on Wednesday, 8 March 2023, at 07.

MFN • 24 Feb 2023 10:00

Jury verdict in patent dispute with DePuy Synthes

A jury in the U.S. Middle District of Florida decided today that Vimian Group AB (publ)’s (“Vimian”) subsidiary, Veterinary Orthopedic Impla...

MFN • 13 Jan 2023 20:15

Conversion of C-shares in Vimian Group AB

The number of votes in Vimian Group AB (publ) (“Vimian”) has changed as a result of conversions of in total 6,019,086 C-shares into ordinary...

MFN • 10 Jan 2023 14:35

Colleen Flesher appointed new Co-CEO of Vimian’s MedTech segment and member of the Vimian group management team

Colleen Flesher, currently COO Movora, has been appointed new Co-CEO of Movora, the operating company within Vimian’s MedTech segment.

MFN • 23 Nov 2022 08:00

Vimian’s Interim Report for the third quarter of 2022

Strengthened market positions in challenging macroeconomy

MFN • 16 Nov 2022 07:45

Invitation to Vimian’s Interim Report for the third quarter of 2022

Vimian Group AB will publish its Interim Report for the period of July-September 2022 on Wednesday, 16 November 2022, at 07.

MFN • 07 Nov 2022 11:00

Nomination Committee for Vimian’s 2023 Annual General Meeting

The Nomination Committee for Vimian Group has been appointed.

MFN • 24 Oct 2022 10:00

Kommuniké från extra bolagsstämma i Vimian Group AB (publ) den 3 oktober 2022

Vimian har idag den 3 oktober 2022 hållit extra bolagsstämma.

MFN • 03 Oct 2022 11:15

Kallelse till extra bolagsstämma i Vimian Group AB (publ)

Vimian Group AB (publ) (”Vimian”), org.nr 559234-8923, med säte i Stockholm, kallar till extra bolagsstämma den 3 oktober 2022.

MFN • 16 Sep 2022 13:00

Vimian carries out a directed share issue of 51,727,442 shares, raising proceeds of approximately SEK 1.5 billion

Vimian Group AB (publ) (“Vimian” or the “Company”) has, as indicated in the Company’s press release earlier today, resolved to carry out a d...

MFN • 14 Sep 2022 23:50

Vimian announces its intention to carry out a directed share issue to continue capturing strategic M&A opportunities

Vimian Group AB (publ) ("Vimian" or the "Company") has mandated Carnegie Investment Bank AB (publ) (“Carnegie”) to evaluate the conditions f...

MFN • 14 Sep 2022 17:31

Carl-Johan Ehn appointed General Counsel and member of Vimian’s management team

Vimian appoints Carl-Johan Ehn as General Counsel and member of the Vimian Group management team as of 7 September 2022.

MFN • 07 Sep 2022 08:00

Vimian’s Interim Report for the second quarter of 2022

Solid performance in challenging macroeconomic environment

MFN • 24 Aug 2022 07:45

Invitation to Vimian’s Interim Report for the second quarter of 2022

Vimian Group AB will publish its Interim Report for the period of April-June 2022 on Wednesday, 24 August 2022, at 07.

MFN • 16 Aug 2022 10:00

Vimian Group acquires veterinary orthopedic implants business in the US

Vimian Group has acquired the assets of New Generation Devices (NGD), a veterinary orthopedic implants company in New Jersey, US.

MFN • 04 Aug 2022 08:00

Vimian Group acquires leading online platform for veterinary pharmaceuticals

Vimian Group has acquired Heiland GmbH (“heiland.com”), a leading online ordering platform offering veterinary pharmaceuticals and other vet...

MFN • 02 Aug 2022 08:00

Carl-Johan Zetterberg Boudrie appointed new CFO and member of Vimian’s management team

Vimian Group appoints Carl-Johan Zetterberg Boudrie as new Chief Financial Officer (CFO) and intends to continue to build out its finance or...

MFN • 14 Jul 2022 08:00

Kommuniké från årsstämman i Vimian Group AB (publ) den 2 juni 2022

Vimian har idag den 2 juni 2022 hållit årsstämma. Årsstämman genomfördes med fysisk närvaro av aktieägare och med möjlighet för aktieägare a...

MFN • 02 Jun 2022 11:45

Vimian’s Interim Report for the first quarter of 2022

Strong growth and profitability in Q1

MFN • 24 May 2022 07:45

Invitation to Vimian’s Interim Report for the first quarter of 2022

Vimian Group AB will publish its Interim Report for the period of January-March 2022 on Tuesday, 24 May 2022, at 07.

MFN • 23 May 2022 09:15

Vimian Group publishes Annual Report for 2021

Vimian Group has published its Annual Report for 2021.

MFN • 05 May 2022 08:30

Kallelse till årsstämma i Vimian Group AB (publ)

Vimian Group AB (publ) (”Vimian”), org.nr 559234-8923, med säte i Stockholm, kallar till årsstämma den 2 juni 2022 kl.

MFN • 03 May 2022 10:00

Vimian Group acquires product portfolios of veterinary surgical instruments and orthopedic implants

Vimian Group has acquired two product portfolios of veterinary surgical instruments and orthopedic implants in the US.

MFN • 13 Apr 2022 08:00

Vimian Group acquires one of the leading providers of procurement and support services to veterinary clinics in the US

Vimian Group has acquired Vertical Vet, LLC (VerticalVet), one of the leading providers of procurement and support services to more than 1,1...

MFN • 04 Apr 2022 08:10

Vimian Group acquires veterinary allergy business in the UK

Vimian Group has acquired the veterinary allergy division of AvactaGroup plc in the UK, to strengthen Vimian’s position within veterinary al...

MFN • 16 Mar 2022 08:00

Vimian’s Interim Report for the fourth quarter of 2021

Continued high pace of M&A in Q4

MFN • 10 Mar 2022 07:45

Invitation to Vimian’s Interim Report for the fourth quarter of 2021

Vimian Group AB will publish its Interim Report for the period of January-December 2021 on Thursday, 10 March 2022, at 07.

MFN • 24 Feb 2022 10:00

Vimian Group acquires veterinary allergy company in Denmark

Vimian Group has acquired Vet-Allergy, a veterinary allergy company in Denmark, to strengthen its position as a leading provider of veterina...

MFN • 08 Feb 2022 08:00

Vimian Group acquires supplier of veterinary surgical products in New Zealand and Australia

Vimian Group has today signed an agreement to acquire Kahu Vet Group (“Kahuvet”), a supplier of veterinary surgical products in New Zealand ...

MFN • 03 Feb 2022 11:45

Vimian Group acquires leading companion animal health specialty pharmaceuticals company in the UK

Vimian Group has today signed an agreement to acquire Bova Holdings Limited (Bova), a leading companion animal health specialty pharmaceutic...

MFN • 29 Jan 2022 04:05

Vimian Group acquires orthopedic implants company in the US

Vimian Group has today acquired IMEX, an orthopedic implants company in Texas, United States.

MFN • 21 Dec 2021 19:45

Vimian Group acquires pet speciality nutrition company in the United States

Vimian Group today announces the acquisition of GlobalOne Pet Products LLC, a company that offers super premium pet treats and chews across ...

MFN • 04 Dec 2021 00:40

Vimian’s Interim Report for the third quarter of 2021

Solid growth and high M&A activity

MFN • 26 Nov 2021 07:45

Vimian Group enters partnership with biotechnology company Angany Inc. to develop novel vaccines for allergy and atopic dermatitis in companion animals

Vimian Group has signed an agreement to develop new vaccines for allergy and atopic dermatitis together with Angany, a Canadian biotechnolog...

MFN • 23 Nov 2021 08:15

Nomination Committee for Vimian’s 2022 Annual General Meeting

The Nomination Committee for Vimian Group has been appointed.

MFN • 12 Nov 2021 10:30

Vimian Group acquires leading UK company within veterinary surgical products

Vimian Group today announces signing of the acquisition of Freelance Surgical, one of the leading providers of veterinary surgical products ...

MFN • 04 Nov 2021 16:40

Alireza Tajbakhsh appointed new head of Vimian’s Veterinary Services segment and member of the Vimian group management team

Alireza Tajbakhsh, currently COO VetFamily, has been appointed new head and CEO of VetFamily, the operating company within Vimian’s Veterina...

MFN • 02 Nov 2021 08:00

Nextmune, part of Vimian Group, acquires specialist in pet dermatology care

Nextmune, the operating company within Vimian’s Specialty Pharma segment, has signed an agreement to acquire Laboratoire de Dermo-Cosmétique...

MFN • 01 Sep 2021 11:45

Vimian’s Interim Report for the second quarter of 2021

Continued strong organic growth and strengthened market positions in Q2

MFN • 25 Aug 2021 07:45

Indical Bioscience, part of the Vimian group, enters strategic partnership with pioneering air sampling technology company

Indical Bioscience, the operating company within Vimian’s Diagnostics segment, has signed a global development and distribution agreement wi...

MFN • 23 Aug 2021 11:00

Indical Bioscience, part of the Vimian group, acquires Salmonella and antimicrobial resistance diagnostics company

Indical Bioscience, the operating company within Vimian’s Diagnostics segment, has signed an agreement to acquire Check-Points.

MFN • 23 Aug 2021 08:00

Invitation to Vimian’s Interim Report for the second quarter of 2021

Vimian Group AB will publish its Interim Report for the period of January-June 2021 on Wednesday, 25 August 2021, at 07.

MFN • 19 Aug 2021 10:00

VetFamily completes the acquisition of IVA and establishes presence in Australia

VetFamily, the Vimian vertical operating within the Veterinary Services segment, today announces the completion of the acquisition of Indepe...

MFN • 01 Jul 2021 12:00

Excercise of over-allotment option and end of stabilisation period

Carnegie Investment Bank AB (publ) ("Carnegie"), in its capacity as stabilisation manager, today notified Vimian Group AB (publ) ("Vimian" o...

MFN • 30 Jun 2021 18:00

Stabilisation notice

Carnegie Investment Bank AB (publ) ("Carnegie"), in its capacity as stabilisation manager, notifies that stabilisation measures have been un...

MFN • 24 Jun 2021 18:00

VIMIAN INTENDS TO CARRY OUT A PRIVATE PLACEMENT AND SUBSEQUENT LISTING OF ITS ORDINARY SHARES ON NASDAQ FIRST NORTH GROWTH MARKET

Vimian Group AB (publ) (“Vimian”, the “Group” or the “Company”), a global, fast-growing and innovation-driven animal health business, offeri...

MFN • 09 Jun 2021 08:00

Fidelio skapar Vimian – ett globalt ”powerhouse” inom djurhälsa

Efter ett decennium av att framgångsrikt investerat i och utvecklat ledande aktörer på den snabbt växande marknaden för djurhälsa, offentlig...

MFN • 15 Apr 2021 07:50